SClurnge: Good to see you're hanging in there. We are getting dilution for sure, but it's undeniable PYC is growing as a company at the same time.
Look how far we've come in 12mths.
1 April 2010
- Roche stage 1 in progress
- MRC/Hutchison research on going
- CD40L progressing
- other in-house research on hold
1 April 2011
- Roche stage 1 successfully completed
- Roche fondling PYCs other bits to see what whistles
- Already months into AstraZeneca stage 1.
- Signed deal with Pfizer to find possible vaccines.
- Concluded initial stage with MRC/Hutchison
- PYC/Cambridge Uni developing startup company with cutting edge technology.
- CD40L progressing
- IMO in a matter of weeks this list could be out of date.
- did I miss anything
Our stake is diminishing in an expanding company.
ST
- Forums
- ASX - By Stock
- Ann: Appendix 3B 1st Tranche A
PYC
pyc therapeutics limited
Add to My Watchlist
0.37%
!
$1.37

SClurnge: Good to see you're hanging in there. We are getting...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.37 |
Change
0.005(0.37%) |
Mkt cap ! $836.9M |
Open | High | Low | Value | Volume |
$1.37 | $1.44 | $1.34 | $553.4K | 406.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6504 | $1.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.37 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7724 | 1.370 |
1 | 703 | 1.365 |
1 | 703 | 1.360 |
2 | 10375 | 1.355 |
2 | 1963 | 1.350 |
Price($) | Vol. | No. |
---|---|---|
1.390 | 5000 | 1 |
1.395 | 862 | 1 |
1.400 | 9349 | 3 |
1.415 | 6530 | 1 |
1.425 | 5100 | 1 |
Last trade - 15.26pm 16/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
WCE
WEST COAST SILVER LIMITED
Bruce Garlick, Executive Chairman
Bruce Garlick
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online